Key features of innovation in the pharmaceutical industry -- How to achieve freedom to operate (FTO) -- Dealing with adverse patents -- Structure and operation

Drug repurposing is the development of existing drugs for new uses: given that 9 in 10 drugs that enter drug development are never marketed and therefore repres

Die FTO-Lizensierung in der Pharmaindustrie verdient aufgrund der wirtschaftlichen Bedeutsamkeit des Marktes, der hohen Kosten von Forschung und Entwicklung, ei

This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in develop

These Guidelines are designed both for general users of patent information, as well as for those involved in producing Patent Landscape Reports (PLRs). They pro